<i>In vitro</i> activity and genomic characterization of KPC-producing <i>Klebsiella pneumoniae</i> clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre obse

New BLICs were shown to be the most widely active therapeutic option against KPC-Kp clinical isolates collected in Italy. Ceftazidime/avibactam resistance is mainly driven by the expression of KPC variants, whereas the loss of function of the OmpK35 and OmpK36 porins appears to play a key but not exclusive role in the development of meropenem/vaborbactam and/or imipenem/relebactam resistance.

Authors

Institutions

Publication Details

Journal
Journal of Antimicrobial Chemotherapy
Published
2024-12-19
DOI
https://doi.org/10.1093/jac/dkae450
Citations
12
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
2.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre obse

Guido Antonelli, Gabriele Bianco, Rossana Cavallo, Rita Greco et al.
12 citations
Journal of Antimicrobial Chemotherapy
Antibiotic Resistance in Bacteria
2.04
article

In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre obse

Guido Antonelli, Gabriele Bianco, Rossana Cavallo, Rita Greco, Paolo Gaibani, Federica Sacco, Claudio Farina, Matteo Boattini, Sofia Chiatamone Ranieri, Simone Ambretti, Annarita Mazzariol, Bianca Paglietti, Francesco Broccolo, Maura Fiamma, Linda Degl’Innocenti, Teresa Fasciana, Cristina Costa, Laura Isabella Lupo, Davide Gibellini, Sara Comini, Angela Quirino
article en
12 citations

Abstract

New BLICs were shown to be the most widely active therapeutic option against KPC-Kp clinical isolates collected in Italy. Ceftazidime/avibactam resistance is mainly driven by the expression of KPC variants, whereas the loss of function of the OmpK35 and OmpK36 porins appears to play a key but not exclusive role in the development of meropenem/vaborbactam and/or imipenem/relebactam resistance.

Journal of Antimicrobial ChemotherapyVol. 80(2)
University of Verona (IT), University of Teramo (IT), University of Salento (IT), University of Sassari (IT), Policlinico Umberto I (IT), Magna Graecia University (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Ospedale Antonio Cardarelli (IT), Azienda Ospedaliera Universitaria Integrata Verona (IT), Ospedale Papa Giovanni XXIII (IT), ATS Sardegna (Italy) (IT), Azienda USL di Bologna (IT), Department of Medical Sciences (BY), Ospedale Vito Fazzi (IT), Carlo Forlanini Hospital (IT), University of Turin (IT), Sapienza University of Rome (IT), University of Palermo (IT), University of Bologna (IT)
Good health and well-being
Openalex Percentile: Top 12%
Antibiotic Resistance in Bacteria
2.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.